NC Approves Medicaid Expansion, Reversing Long Opposition
White House Steps Up Fight Against Possible Winter COVID-19 Surge
December 15, 2022
by Dan McCue
WASHINGTON — Three months after stopping the practice, the Biden administration is once again making free COVID-19 tests available to all U.S. households.
The goal, administration officials said, is to stop a potential surge in COVID-19 cases heading into winter.
Starting Thursday, households will be able to request four rapid virus tests through covidtests.gov.
The renewed effort to combat the coronavirus comes after an uptick of cases after the recent Thanksgiving holiday.
A further increase in cases is expected following Christmas and New Year’s, holidays that are marked by travel and indoor entertaining.
The administration also announced Thursday that it is putting personnel and equipment on standby should they be needed to help overwhelmed hospitals and nursing homes.
The White House is also doubling down on its efforts to encourage people to get the updated bivalent COVID-19 vaccines, which are more effective at protecting against serious illness than the vaccines administered months ago.
Dan can be reached at dan@thewellnews.com and @DanMcCue
In The News
Health
Voting
Health
March 23, 2023
by NC Approves Medicaid Expansion, Reversing Long Opposition
NC Approves Medicaid Expansion, Reversing Long Opposition
RALEIGH, N.C. (AP) — A Medicaid expansion deal in North Carolina received final legislative approval on Thursday, ending a decade of debate... Read More
RALEIGH, N.C. (AP) — A Medicaid expansion deal in North Carolina received final legislative approval on Thursday, ending a decade of debate over whether the closely politically divided state should accept the federal government's coverage for hundreds of thousands of low-income adults. North Carolina is one of several... Read More
March 22, 2023
by Tom Ramstack
Sens. Press Moderna Chief Exec on COVID Vaccine Price Hike
WASHINGTON — The chief executive of Moderna Inc. defended his plan to quadruple the price of the COVID-19 vaccine during... Read More
WASHINGTON — The chief executive of Moderna Inc. defended his plan to quadruple the price of the COVID-19 vaccine during a Senate hearing Wednesday by saying his company is preparing for a sharp decline in demand. With as much as a 90% drop in customers as... Read More
March 22, 2023
by What Made Beethoven Sick? DNA From His Hair Offers Clues
What Made Beethoven Sick? DNA From His Hair Offers Clues
NEW YORK (AP) — Nearly 200 years after Ludwig van Beethoven's death, researchers pulled DNA from strands of his hair,... Read More
NEW YORK (AP) — Nearly 200 years after Ludwig van Beethoven's death, researchers pulled DNA from strands of his hair, searching for clues about the health problems and hearing loss that plagued him. They weren't able to crack the case of the German composer's deafness or... Read More
March 21, 2023
by Superbug Fungus Cases Rose Dramatically During Pandemic
Superbug Fungus Cases Rose Dramatically During Pandemic
NEW YORK (AP) — U.S. cases of a dangerous fungus tripled over just three years, and more than half of... Read More
NEW YORK (AP) — U.S. cases of a dangerous fungus tripled over just three years, and more than half of states have now reported it, according to a new study. The COVID-19 pandemic likely drove part of the increase, researchers at the Centers for Disease Control... Read More
March 20, 2023
by Dan McCue
Biden Signs COVID Origin Act
WASHINGTON — A week after the House overwhelmingly voted to declassify any and all information related to the origin of... Read More
WASHINGTON — A week after the House overwhelmingly voted to declassify any and all information related to the origin of COVID-19, President Joe Biden signed the measure into law, saying, “I share the Congress’ goal of releasing as much information as possible” about the virus. The... Read More
March 20, 2023
by Dan McCue
Karuna Could Submit Schizophrenia Drug to FDA by Mid-Year
BOSTON — Encouraged by positive topline results from its phase 3 trial for its new therapy for adults with schizophrenia,... Read More
BOSTON — Encouraged by positive topline results from its phase 3 trial for its new therapy for adults with schizophrenia, Karuna Therapeutics announced Monday that it is on track to submit KarXT to the Food and Drug Administration for approval by summer. If that comes to... Read More
News From The Well
